nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.263	0.386	CbGbCtD
Arformoterol—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.219	0.321	CbGbCtD
Arformoterol—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.2	0.293	CbGbCtD
Arformoterol—Tonsillitis—Cyclosporine—focal segmental glomerulosclerosis	0.0202	0.0634	CcSEcCtD
Arformoterol—Toxicity to various agents—Cyclosporine—focal segmental glomerulosclerosis	0.0178	0.0561	CcSEcCtD
Arformoterol—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0169	0.0531	CcSEcCtD
Arformoterol—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0336	CcSEcCtD
Arformoterol—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00921	0.0289	CcSEcCtD
Arformoterol—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00867	0.0272	CcSEcCtD
Arformoterol—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00707	0.0222	CcSEcCtD
Arformoterol—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00677	0.0213	CcSEcCtD
Arformoterol—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00644	0.0202	CcSEcCtD
Arformoterol—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00568	0.0179	CcSEcCtD
Arformoterol—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00564	0.0177	CcSEcCtD
Arformoterol—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00564	0.0177	CcSEcCtD
Arformoterol—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00553	0.0174	CcSEcCtD
Arformoterol—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00549	0.0173	CcSEcCtD
Arformoterol—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00546	0.0172	CcSEcCtD
Arformoterol—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00501	0.0157	CcSEcCtD
Arformoterol—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.0153	CcSEcCtD
Arformoterol—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00468	0.0147	CcSEcCtD
Arformoterol—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00461	0.0145	CcSEcCtD
Arformoterol—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.014	CcSEcCtD
Arformoterol—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.0131	CcSEcCtD
Arformoterol—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00403	0.0127	CcSEcCtD
Arformoterol—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00381	0.012	CcSEcCtD
Arformoterol—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00379	0.0119	CcSEcCtD
Arformoterol—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00339	0.0107	CcSEcCtD
Arformoterol—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.0105	CcSEcCtD
Arformoterol—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00327	0.0103	CcSEcCtD
Arformoterol—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00989	CcSEcCtD
Arformoterol—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.00967	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00934	CcSEcCtD
Arformoterol—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.00907	CcSEcCtD
Arformoterol—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00883	CcSEcCtD
Arformoterol—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.00878	CcSEcCtD
Arformoterol—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.00871	CcSEcCtD
Arformoterol—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.00871	CcSEcCtD
Arformoterol—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.00855	CcSEcCtD
Arformoterol—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00267	0.00841	CcSEcCtD
Arformoterol—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00807	CcSEcCtD
Arformoterol—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00798	CcSEcCtD
Arformoterol—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00795	CcSEcCtD
Arformoterol—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00791	CcSEcCtD
Arformoterol—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00789	CcSEcCtD
Arformoterol—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00775	CcSEcCtD
Arformoterol—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00725	CcSEcCtD
Arformoterol—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00719	CcSEcCtD
Arformoterol—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00705	CcSEcCtD
Arformoterol—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.007	CcSEcCtD
Arformoterol—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.00687	CcSEcCtD
Arformoterol—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.00686	CcSEcCtD
Arformoterol—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.0068	CcSEcCtD
Arformoterol—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.00673	CcSEcCtD
Arformoterol—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00656	CcSEcCtD
Arformoterol—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.0065	CcSEcCtD
Arformoterol—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00644	CcSEcCtD
Arformoterol—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.0064	CcSEcCtD
Arformoterol—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00632	CcSEcCtD
Arformoterol—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00611	CcSEcCtD
Arformoterol—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00605	CcSEcCtD
Arformoterol—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00596	CcSEcCtD
Arformoterol—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00596	CcSEcCtD
Arformoterol—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00596	CcSEcCtD
Arformoterol—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00594	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00592	CcSEcCtD
Arformoterol—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00589	CcSEcCtD
Arformoterol—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00583	CcSEcCtD
Arformoterol—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00572	CcSEcCtD
Arformoterol—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00572	CcSEcCtD
Arformoterol—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00568	CcSEcCtD
Arformoterol—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00561	CcSEcCtD
Arformoterol—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00555	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00521	CcSEcCtD
Arformoterol—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00517	CcSEcCtD
Arformoterol—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.0051	CcSEcCtD
Arformoterol—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00508	CcSEcCtD
Arformoterol—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00503	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00493	CcSEcCtD
Arformoterol—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00493	CcSEcCtD
Arformoterol—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00489	CcSEcCtD
Arformoterol—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00489	CcSEcCtD
Arformoterol—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00471	CcSEcCtD
Arformoterol—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00467	CcSEcCtD
Arformoterol—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00454	CcSEcCtD
Arformoterol—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00452	CcSEcCtD
Arformoterol—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00452	CcSEcCtD
Arformoterol—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00421	CcSEcCtD
Arformoterol—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.0041	CcSEcCtD
Arformoterol—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00404	CcSEcCtD
Arformoterol—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00391	CcSEcCtD
Arformoterol—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00378	CcSEcCtD
Arformoterol—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00363	CcSEcCtD
Arformoterol—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0036	CcSEcCtD
Arformoterol—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0036	CcSEcCtD
Arformoterol—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00358	CcSEcCtD
Arformoterol—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0034	CcSEcCtD
